4//SEC Filing
ABBOTT MEDICAL OPTICS INC 4
Accession 0001256928-09-000018
CIK 0001168335operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 8:25 PM ET
Size
20.0 KB
Accession
0001256928-09-000018
Insider Transaction Report
Form 4
DAVILA ELIZABETH H
Director
Transactions
- Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−6,740$148,280→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-25−3,254→ 0 totalExercise: $30.73From: 2005-05-27Exp: 2014-02-11→ Common Stock (3,254 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-25−109,139→ 0 totalExercise: $30.73From: 2005-05-27Exp: 2014-02-11→ Common Stock (109,139 underlying) - Disposition to Issuer
Common Stock
2009-02-26$22.00/sh−3,650$80,300→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2009-02-25−209,715→ 0 totalExercise: $24.76From: 2005-05-27Exp: 2011-02-13→ Common Stock (209,715 underlying) - Disposition from Tender
Common Stock
2009-02-25$22.00/sh−24,992$549,824→ 0 total - Award
Common Stock
2009-02-25+3,650→ 3,650 total - Award
Common Stock
2009-02-25+6,740→ 6,740 total
Footnotes (5)
- [F1]These shares were tendered to Rainforest Acquisition Inc. ("Purchaser") pursuant to Purchaser?s offer to purchase all of the outstanding shares of Advanced Medical Optics, Inc. (the "Issuer") at a cash purchase price of $22.00 per share, without interest, and subject to any required withholding taxes, subject to the terms described in the Offer to Purchase, filed with the SEC on January 27, 2009, as amended (the "Tender Offer"). Such shares were purchased by Purchaser pursuant to the Tender Offer on February 25, 2009.
- [F2]The exempt restricted stock units (previously reported on Table II) vested in full and were settled for shares of Issuer Common Stock in accordance with the terms of the applicable equity plan. At the effective time of the merger, such shares were cancelled pursuant to the Merger Agreement in exchange for the right to receive cash payment of $22.00 per share in cash (without interest and subject to any required withholding taxes).
- [F3]This previously reported exempt stock option, which became fully vested when it was assumed by the Issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 1,335 shares of Abbott Laboratories common stock at an exercise price of $74.90 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F4]This previously reported exempt stock option, which became fully vested when it was assumed by the Issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 86,044 shares of Abbott Laboratories common stock at an exercise price of $60.35 per share, determined pursuant to a formula set forth in the Merger Agreement.
- [F5]This previously reported exempt stock option, which became fully vested when it was assumed by the Issuer on May 27, 2005, will be exchanged for a fully vested stock option issued by Abbott Laboratories to purchase 44,779 shares of Abbott Laboratories common stock at an exercise price of $74.90 per share, determined pursuant to a formula set forth in the Merger Agreement.
Documents
Issuer
ABBOTT MEDICAL OPTICS INC
CIK 0001168335
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168335
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 8:25 PM ET
- Size
- 20.0 KB